Dexmedetomidine infusion for sedation during awake intubation

Japanese Journal of Anesthesiology

Volumn 57, Issue 6, 2008, Pages 731-734

  Nagashima, Michio ^a   Kunisawa, Takayuki ^a   Takahata, Osamu ^a   Iwasaki, Hiroshi ^a  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

Author keywords

Awake intubation; Dexmedetomidine; Pharmacokinetic simulation analysis

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; DEXMEDETOMIDINE; LIDOCAINE;

ADULT; ARTICLE; BODY MASS; CASE REPORT; COUGHING; DECOMPRESSION SURGERY; DRUG SAFETY; FECES INCONTINENCE; GLOTTIS; HUMAN; HYPOPHARYNX; INTUBATION; LARYNGOSCOPY; LIMB MOVEMENT; MALE; OROPHARYNX; RESPIRATION DEPRESSION; SEDATION; SPINAL CORD DISEASE; URINE INCONTINENCE; WAKEFULNESS;

ADULT; DECOMPRESSION, SURGICAL; DEXAMETHASONE; GLUCOCORTICOIDS; HUMANS; HYPNOTICS AND SEDATIVES; INTUBATION, INTRATRACHEAL; MALE; OBESITY, MORBID; SPINAL CORD DISEASES; THORACOTOMY;

EID: 46449103557     PISSN: 00214892     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Mallampati SR, Gatt SP, Gugino LD, Desai SP, Waraksa B, Freiberger D, et al. A clinical sign to predict difficult tracheal intubation : a prospective study. Can Anaesth Soc J 1985 ; 32 : 429-34.
2. Ramsay MA, Savege TM, Simpson BR, Goodwin R. Controlled sedation with alphaxalone-alphadolone. BMJ 1974 ; 22 : 656-9.
3. Naguib M, Samarkandi AH, El-Din ME, Abdullah K, Khaled M, Alharby SW. The dose of succinylcholine required for excellent endotracheal intubating conditions. Anesth Analg 2006 ; 102 : 151-5.
4. Shafer SL. STANPUMP is available at : http://anesthesia.stanford.edu/ pkpd. Accessed May 20, 2007.
5. Dyck JB, Maze M, Haack C, Vuorilehto L, Shafer SL. The pharmacokinetics and hemodynamic effects of intravenous and intramuscular dexmedetomidine hydrochloride in adult human volunteers. Anesthesiology 1993 ; 78 : 813-20.
6. Dyck JB, Maze M, Haack C, Azarnoff DL, Vuorilehto L, Shafer SL. Computer-controlled infusion of intravenous dexmedetomidine hydrochloride in adult human volunteers. Anesthesiology 1993 ; 78 : 821-8.
7. Shafer SL, Varvel JR, Aziz N, Scott JC. Pharmacokinetics of fentanyl administered by computer-controlled infusion pump. Anesthesiology 1990 ; 73 : 1091-102.
8. Bergese SD, Khabiri B, Roberts WD, Howie MB, McSweeney TD, Gerhardt MA. Dexmedetomidine for conscious sedation in difficult awake fiberoptic intubation cases. J Clin Anesth 2007 ; 19 : 141-4.
9. Ramsay MA, Luterman DL. Dexmedetomidine as a total intravenous anesthetic agent. Anesthesiology 2004 ; 101 : 787-90.
10. Ebert TJ, Hall JE, Barney JA, Uhrich TD, Colinco MD. The effects of increasing plasma concentrations of dexmedetomidine in humans. Anesthesiology 2000 ; 93 : 382-94.
11. Japanese source
12. Japanese source
13. Grant SA, Breslin DS, MacLeod DB, Gleason D, Martin G. Dexmedetomidine infusion for sedation during fiberoptic intubation : a report of three cases. J Clin Anesth 2004 ; 16 : 124-6.
14. Kamibayashi T, Maze M. Clinical uses of alpha2-adrenergic agonists. Anesthesiology 2000 ; 93 : 1345-9.
15. Japanese source
16. Japanese source
17. Ebert TJ, Hall JE, Barney JA, Uhrich TD, Colinco MD. The effects of increasing plasma concentrations of dexmedetomidine in humans. Anesthesiology 2000 ; 93 : 382-94.
18. Bloor BC, Ward DS, Belleville JP, Maze M. Effects of intravenous dexmedetomidine in humans. II. Hemodynamic changes. Anesthesiology 1992 ; 77 : 1134-42.
19. Aantaa R. Assessment of the sedative effects of dexmedetomidine, an alpha 2-adrenoceptor agonist, with analysis of saccadic eye movements. Pharmacol Toxicol 1991 ; 68 : 394-8.